GLP-1 fusion proteins

• 收藏
• 分享

专利权人:

ELI LILLY AND COMPANY

发明人:

GLAESNER WOLFGANG,MICANOVIC RADMILLA,TSCHANG SHENG-HUNG RAINBOW

申请号：

SK6702003

公开号：

SK288342B6

申请日:

2001.11.29

申请国别(地区):

SK

年份:

2016

代理人:

摘要：

The invention relates to analogs, derivatives and fragments of GLP-1, fused to polypeptides that have the effect of extending the in vivo half-life of the peptides. Said polypeptides are the Fc portion of an immunoglobulin, an analog or a fragment thereof. Fused proteins may be used for the treatment of non-insulin dependent diabetes or obesity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/